NPI: 1184677163 · NORTH HIGHLANDS, CA 95660 · Community Health Clinic/Center · NPI assigned 05/18/2006
Authorized official MOTSIFF, TOM controls 20+ related entities in our dataset. Read more
| Authorized Official | MOTSIFF, TOM (CFO) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: MOTSIFF, TOM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,081 | $1.31M |
| 2019 | 14,573 | $525K |
| 2020 | 5,706 | $267K |
| 2021 | 16,054 | $845K |
| 2022 | 29,002 | $789K |
| 2023 | 37,686 | $964K |
| 2024 | 38,825 | $989K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J3490 | Unclassified drugs | 21,021 | 16,855 | $627K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,648 | 8,291 | $621K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 881 | 880 | $612K |
| S4993 | Contraceptive pills for birth control | 4,510 | 4,449 | $467K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8,622 | 8,406 | $380K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3,608 | 3,601 | $349K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,946 | 2,902 | $334K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 1,152 | 1,141 | $287K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9,130 | 8,753 | $272K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,663 | 1,660 | $271K |
| J7304 | Contraceptive supply, hormone containing patch, each | 294 | 286 | $263K |
| 99201 | 1,698 | 1,668 | $183K | |
| 87806 | 11,808 | 10,693 | $169K | |
| 11981 | 845 | 845 | $158K | |
| A4267 | Contraceptive supply, condom, male, each | 7,992 | 7,827 | $94K |
| 58300 | 1,034 | 521 | $84K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7,333 | 7,286 | $69K |
| 99401 | 2,617 | 2,572 | $50K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 90 | 90 | $48K |
| 11976 | 522 | 274 | $42K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 3,092 | 3,092 | $39K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,527 | 1,472 | $31K |
| S0190 | Mifepristone, oral, 200 mg | 1,085 | 1,083 | $30K |
| 81025 | 10,945 | 10,769 | $24K | |
| 58301 | 814 | 419 | $24K | |
| S5000 | Prescription drug, generic | 2,864 | 2,640 | $22K |
| 99000 | 10,041 | 9,785 | $22K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11,492 | 11,388 | $21K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11,465 | 11,361 | $21K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 133 | 133 | $20K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 5,344 | 5,246 | $12K |
| 83986 | 6,391 | 5,802 | $12K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 24 | 24 | $6K |
| 11982 | 411 | 206 | $5K | |
| 85018 | 809 | 761 | $4K | |
| 99402 | 128 | 128 | $4K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 13 | 13 | $4K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 795 | 704 | $2K |
| S0191 | Misoprostol, oral, 200 mcg | 1,172 | 1,153 | $2K |
| 81002 | 1,372 | 1,344 | $2K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 147 | 145 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 336 | 321 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 83 | 55 | $240.81 |
| 0270 | 17 | 12 | $213.75 | |
| 87210 | 13 | 12 | $0.00 |